Mindanao Examiner Regional Newspaper : DOH resumes use of As

DOH resumes use of AstraZeneca vaccines for all age groups
THE DEPARTMENT of Health (DOH) has reallowed the use of the Oxford AstraZeneca vaccine for all age groups.  
In a statement on Friday, the DOH said based on the recommendation of the Food and Drug Administration (FDA) and the DOH All Experts Group on Vaccines (DOH-AEGV), it was concluded that there are currently “no known risk factors” for vaccine-induced thrombosis and thrombocytopenia (VITT)—a very rare condition of blood clots associated with low platelet counts that occur four to 28 days after receiving a viral vector vaccine such as AstraZeneca.
It noted that the benefits of receiving the vaccine “still outweigh the risk”.

Related Keywords

Oxford Astrazeneca , Raymond Carl Dela Cruz , Technology Vaccine Expert Panel , National Adverse Events Following Immunization Committee , Experts Group On Vaccines , Philippine College Of Hematology , Drug Administration , National Immunization Technical Advisory Group , Astrazeneca , Technical Advisory Group For Covid , Department Of Science , Health Technology Assessment Council , Experts Group , Philippine College , Transfusion Medicine , Advisory Group , ரேமஂட் கார்ல் டெலா குரூஸ் , தொழில்நுட்பம் தடுப்பூசி நிபுணர் குழு , பிலிப்பைன் கல்லூரி ஆஃப் ஹீமாட்டாலஜி , துறை ஆஃப் அறிவியல் , ஆரோக்கியம் தொழில்நுட்பம் மதிப்பீடு சபை , நிபுணர்கள் குழு , பிலிப்பைன் கல்லூரி , பரிமாற்றம் மருந்து ,